China Steel Corporation (LUX:CHSTC)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,550	8,830	12,194	13,991	17,289	11,101
Market Cap Growth	-10.16%	-27.59%	-12.85%	-19.08%	55.74%	1.16%
Enterprise Value	16,542	16,843	19,901	21,825	23,828	18,283
Last Close Price	11.17	11.45	15.56	17.29	19.20	12.27
PE Ratio	203.10	155.68	253.63	25.91	8.80	458.37
PS Ratio	0.88	0.83	1.14	1.02	1.16	1.21
PB Ratio	0.90	0.88	1.21	1.29	1.41	1.18
P/TBV Ratio	1.02	1.00	1.36	1.44	1.57	1.31
P/FCF Ratio	-	-	377.40	-	10.85	10.48
P/OCF Ratio	-	7.09	10.67	18.87	7.64	6.04
EV/Sales Ratio	1.62	1.59	1.86	1.59	1.60	2.00
EV/EBITDA Ratio	15.85	17.29	19.65	13.97	6.55	17.82
EV/EBIT Ratio	184.64	275.35	192.62	39.17	9.03	218.72
EV/FCF Ratio	243.90	-	615.95	-	14.95	17.26
Debt / Equity Ratio	0.80	0.80	0.77	0.69	0.48	0.71
Debt / EBITDA Ratio	7.79	7.93	7.33	4.67	1.61	6.29
Debt / FCF Ratio	113.17	-	239.62	-	3.71	6.29
Asset Turnover	0.50	0.53	0.53	0.66	0.71	0.48
Inventory Turnover	2.89	3.03	2.75	3.20	3.59	3.40
Quick Ratio	0.50	0.48	0.36	0.38	0.41	0.40
Current Ratio	1.38	1.31	1.18	1.27	1.30	1.04
Return on Equity (ROE)	1.03%	1.13%	1.01%	4.84%	19.41%	0.69%
Return on Assets (ROA)	0.24%	0.19%	0.32%	1.67%	7.85%	0.28%
Return on Capital (ROIC)	0.27%	0.21%	0.36%	1.94%	9.23%	0.32%
Return on Capital Employed (ROCE)	0.50%	0.40%	0.70%	3.50%	15.80%	0.60%
Earnings Yield	0.49%	0.66%	0.41%	3.87%	11.39%	0.23%
FCF Yield	0.79%	-0.16%	0.27%	-1.64%	9.22%	9.54%
Dividend Yield	1.04%	0.08%	0.07%	0.18%	0.51%	0.07%
Payout Ratio	348.13%	278.30%	937.10%	274.82%	7.70%	893.58%
Buyback Yield / Dilution	0.70%	0.99%	0.46%	0.67%	-1.02%	0.21%
Total Shareholder Return	1.75%	1.08%	0.52%	0.85%	-0.51%	0.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.